Encyclopedia of Heart Diseases

2011 Edition
| Editors: M. Gabriel Khan


Reference work entry
DOI: https://doi.org/10.1007/978-1-60761-219-3_10


The largest artery in the body is the aorta, which takes blood from the heart and runs from the chest into the abdomen, lying against the spine until it reaches the pelvis. It divides at that point into iliac arteries that supply blood to the pelvis, buttocks, and legs (see Fig. 1). Because the aorta takes the full force of blood ejected from the heart, it is the most likely artery in the body to weaken and expand to form an  aneurysm.
This is a preview of subscription content, log in to check access.



  1. Brady AR, Thompson SG, Greenhalgh RM et al (2003) Cardiovascular risk factors and abdominal aortic aneurysm expansion: only smoking counts. Br J Surg 90:492–493Google Scholar
  2. Brooke BS, Habashi JP, Judge DP et al (2008) Angiotensin ii blockade and aortic-root dilation in Marfan’s syndrome. N Engl J Med 358:2787–2795PubMedGoogle Scholar
  3. Chuter TA, Rapp JH, Hiramoto JS et al (2008) Endovascular treatment of thoracoabdominal aortic aneurysms. J Vasc Surg 47:6–16PubMedGoogle Scholar
  4. Dietz HC, Cutting GR, Pyeritz RE et al (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352:337–339PubMedGoogle Scholar
  5. Fedak PW, de Sa MP, Verma S et al (2003) Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. J Thorac Cardiovasc Surg 126:797–806PubMedGoogle Scholar
  6. Golledge J, Eagle K (2008) Aortic dissection. Lancet 372:55–66PubMedGoogle Scholar
  7. Greenberg RK, Lytle B (2008) Endovascular repair of thoracoabdominal aneurysms. Circulation 117:2288–2296PubMedGoogle Scholar
  8. Greenhalgh RM, Powell JT (2008) Endovascular Repair of Abdominal Aortic Aneurysm. NEJM 358:494–501PubMedGoogle Scholar
  9. Habashi JP, Judge DP, Holm TM et al (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312:117–121PubMedGoogle Scholar
  10. Johnson TR, Nikolaou K, Wintersperger BJ et al (2007) ECG-gated 64-MDCT angiography in the differential diagnosis of acute chest pain. Am J Roentgenol 188:76–82Google Scholar
  11. Khan M Gabriel (1996) Angina. In: Heart Disease Diagnosis and Therapy, a Practical Approach, Williams and Wilkins, Baltimore, p 157Google Scholar
  12. Khan M Gabriel (2003) Results of recent Clinical Trials. In: Cardiac Drug Therapy. WB Saunders/Elsevier, Philadelphia, 6th ed, p 502Google Scholar
  13. Khan M Gabriel (2005) Angina, which beta blocker to choose. In: Heart Disease Diagnosis and Therapy, a Practical Approach, 2nd ed. Humana Press: Totowa, NJ, pp 150–152Google Scholar
  14. Khan M Gabriel (2007) Beta blockers. In: Cardiac drug therapy, 7th edn. Humana Press/Springer, New York, p 30Google Scholar
  15. Kim LG, Scott RAP, Ashton HA et al (2007) Multicentre Aneurysm Screening Study Group: A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med 146:699–706PubMedGoogle Scholar
  16. Lacro RV, Dietz HC, Wruck LM et al (2007) Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J 154:624–631PubMedGoogle Scholar
  17. Lederle FA, Wilson SE, Johnson GR et al (2002) For the Aneurysm Detection and Management Veterans Affairs Cooperative Study Group. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 346:1437–1444PubMedGoogle Scholar
  18. Lederle FA, Freischlag JA, Kyriakides TC et al for the Open Versus Endovascular Repair (OVER) Veterans Affairs Cooperative Study Group (2009) Outcomes following endovascular vs open repair of abdominal aortic aneurysm. A randomized trial. JAMA 302(14):1535–1542Google Scholar
  19. Mochizuki S, Dahlof B, Shimizu M et al (2007) Valsartan in a Japanese population with hypertension and other cardiovascular disease: a randomised, open-label, blinded end-point morbidity-mortality study. Lancet 369:1431–1439PubMedGoogle Scholar
  20. Nienaber CA, Eagle KA (2003a) Aortic dissection: new frontiers in diagnosis and management. Part I: From etiology to diagnostic strategies. Circulation 108:628–635PubMedGoogle Scholar
  21. Nienaber CA, Eagle KA (2003b) Aortic dissection: new frontiers in diagnosis and management. Part II: Therapeutic management and follow-up. Circulation 108:772PubMedGoogle Scholar
  22. Parodi JC, Palmaz JC, Barone HD (1991) Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 5:491–499PubMedGoogle Scholar
  23. Pearson GD, Devereux R, Loeys B et al (2008) Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on Research in Marfan Syndrome and Related Disorders. Circulation 118:785–791PubMedGoogle Scholar
  24. Powell JT, Greenhalgh RM (2003) Small abdominal aortic aneurysms. N Engl J Med 348:1895–1901PubMedGoogle Scholar
  25. Pyeritz RE (2007) Marfan syndrome and related disorders. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR (eds) Emery and Rimoin’s Principles and Practice of Medical Genetics. 5th ed. London, UK: Churchill Livingstone 3:3579–3624Google Scholar
  26. Shiga T, Wajima Z, Apfel CC et al (2006) Diagnostic accuracy of transesophageal echocardiography, helical computed tomography, and magnetic resonance imaging for suspected thoracic aortic dissection: systematic review and meta-analysis. Arch Intern Med 166:1350–1356PubMedGoogle Scholar
  27. Shores J, Berger KR, Murphy EA et al (1994) Progression of aortic dilatation and the benefi t of long-term beta-adrenergic blockade in Marfan’s syndrome. N Engl J Med 330:1335–1341PubMedGoogle Scholar

Suggested Reading

  1. Badger SA, O’Donnell ME, Sharif MA et al (2008) Risk factors for abdominal aortic aneurysm and the influence of social deprivation. Angiology 59:559–566PubMedGoogle Scholar
  2. Diehm N, Baumgartner I (2009) Determinants of aneurysmal aortic disease. Circulation 119:2134–2135, http://circ.ahajournals.org/cgi/content/full/119/16/2134
  3. Flu W-J, van Kuijk J-P, Merks EJW et al (2009) Screening for abdominal aortic aneurysms using a dedicated portable ultrasound system: early results. Eur J Echocardiogr 10:602–606 http://ejechocard.oxfordjournals.org/cgi/content/abstract/10/5/602; http://ejechocard.oxfordjournals.org/cgi/content/full/10/5/602PubMedGoogle Scholar
  4. Hay N, McCracken F, Richardson J et al (2009) Endovascular stent-grafts for the treatment of abdominal aortic aneurysms: nice technology appraisal guidance. Heart 95:1798–1800PubMedGoogle Scholar
  5. Kent KC (2010) Endovascular Aneurysm Repair – Is It Durable? NEJM 362:1930–1931PubMedGoogle Scholar
  6. Muehling BM, Bischoff G, Schelzig H (2010) Hybrid procedures for complex thoracoabdominal aortic aneurysms: early results and secondary interventions. Vasc Endovasc Surg 44(2):110–115Google Scholar
  7. Powell JT, Brown LC, Forbes JF et al (2007) Final 12-year follow-up of patients enrolled in the UK Small Aneurysm Trial. Br J Surg 94:702–708PubMedGoogle Scholar
  8. Ramanath VS, Oh JK, Sundt TM III et al (2009) Acute aortic syndromes and thoracic aortic aneurysm. Mayo Clin Proc 84(5):465–481PubMedGoogle Scholar
  9. Schermerhorn M (2009) A 66-year-old man with an abdominal aortic aneurysm. Review of screening and treatment. JAMA 302(18):2015–2022PubMedGoogle Scholar
  10. The United Kingdom EVAR Trial Investigators (2010) Endovascular Repair of Aortic Aneurysm in Patients Physically Ineligible for Open Repair. NEJM 362:1872–1880Google Scholar

Case Studies

  1. EVAR Trial Participants (2005) Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomized controlled trial. Lancet 365:2179–2186. EVAR Google Scholar
  2. The United Kingdom Small Aneurysm Trial Participants (2002) Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 346:14, 45–52Google Scholar

Copyright information

© Springer Science+Business Media LLC 2011